-
By renouncing the special status, Gilead Sciences lets go of tax breaks, fee waivers and seven years without generic competition for remdesivir, its experimental COVID-19 treatment.
-
FDA Commissioner Stephen Hahn speaks with NPR's David Greene about the development of a vaccine and the use of existing drugs to treat COVID-19. Here, a transcript of their full interview.
-
President Trump is expected to hold a press conference, with the latest updates on the coronavirus response. Listen on-air and online at 11:00 a.m. EST…
-
Changes in the way the Food and Drug Administration reviews new medicines means that there are more cures and treatments on the market. But there's also less proof the drugs are safe and effective.
-
A three-drug combination sold under the brand name Trikafta was recently approved by the Food and Drug Administration for people age 12 and older with…
-
Even as the popularity of e-cigarettes like Juul has exploded — with unknown health risks — the federal government has been slow to regulate vaping companies.
-
The U.S. Food and Drug Administration treats most data it gets on the development of new drugs and medical devices as confidential to companies. Critics say making the data public would help patients.
-
When it comes to medicine, the understanding of what is best for a patient can change over time due to new advances made in research, clinical trials and…
-
It’s not easy to keep up with the latest in health and wellness. Each day, new studies, research and developments in health make it difficult to pick out…
-
New York is the second largest maple producing state in the country, producing more than 600,000 gallons of syrup last year, worth about $33 million.But…